RecruitingPhase 2NCT05525273

Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma

Studying Craniopharyngioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Eva Marie Erfurth, MD, PhD
Principal Investigator
Peter Siesjö, MD. PhD.
Department of Neurosurgery, SUS, Lund Sweden
Intervention
Oral dabrafenib and trametinib(drug)
Enrollment
25 enrolled
Eligibility
18 years · All sexes
Timeline
20232028

Study locations (1)

Collaborators

Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05525273 on ClinicalTrials.gov

Other trials for Craniopharyngioma

Additional recruiting or active studies for the same condition.

See all trials for Craniopharyngioma

← Back to all trials